These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 2445471)
1. Diagnostic and prognostic value of RNA-proteolipid in sera of patients with malignant disorders following therapy: first clinical evaluation of a novel tumor marker. Wieczorek AJ; Sitaramam V; Machleidt W; Rhyner K; Perruchoud AP; Block LH Cancer Res; 1987 Dec; 47(23):6407-12. PubMed ID: 2445471 [TBL] [Abstract][Full Text] [Related]
2. [A gene probe test for serum RNA proteolipid in neoplasia]. Wieczorek AJ; Rhyner K Schweiz Med Wochenschr; 1989 Sep; 119(39):1342-3. PubMed ID: 2477896 [TBL] [Abstract][Full Text] [Related]
3. Human tetranectin: methodological and clinical studies. Høgdall CK APMIS Suppl; 1998; 86():1-31. PubMed ID: 9868384 [TBL] [Abstract][Full Text] [Related]
4. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. Griesenberg D; Nürnberg R; Bahlo M; Klapdor R Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173 [TBL] [Abstract][Full Text] [Related]
5. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes. Sher YP; Shih JY; Yang PC; Roffler SR; Chu YW; Wu CW; Yu CL; Peck K Clin Cancer Res; 2005 Jan; 11(1):173-9. PubMed ID: 15671543 [TBL] [Abstract][Full Text] [Related]
6. [Molecular diagnostic detection of circulating tumor cells and their prognostic implications]. Nakanishi H; Tatematsu M Gan To Kagaku Ryoho; 1997 Feb; 24(3):257-65. PubMed ID: 9051125 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic potential of circulating nucleic acids for oncology. Goessl C Expert Rev Mol Diagn; 2003 Jul; 3(4):431-42. PubMed ID: 12877383 [TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of circulating nucleosomes in cancer. Holdenrieder S; Nagel D; Schalhorn A; Heinemann V; Wilkowski R; von Pawel J; Raith H; Feldmann K; Kremer AE; Müller S; Geiger S; Hamann GF; Seidel D; Stieber P Ann N Y Acad Sci; 2008 Aug; 1137():180-9. PubMed ID: 18837945 [TBL] [Abstract][Full Text] [Related]
9. Serum cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as a prognostic tumor marker in patients with esophageal squamous cell carcinoma. Nabeya Y; Shimada H; Okazumi S; Matsubara H; Gunji Y; Suzuki T; Ochiai T Cancer; 2002 Feb; 94(4):940-9. PubMed ID: 11920462 [TBL] [Abstract][Full Text] [Related]
10. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407 [TBL] [Abstract][Full Text] [Related]
11. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer. Hara N; Kasahara T; Kawasaki T; Bilim V; Obara K; Takahashi K; Tomita Y Clin Cancer Res; 2002 Jun; 8(6):1794-9. PubMed ID: 12060619 [TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation on an enzyme immunoassay kit for basic fetoprotein (BFP). (1) Clinical usefulness of BFP]. Ishii M; Hattori N; Kato T; Mochizuki M; Kamidono S; Sawabu N; Kawada Y; Kawai T; Abe O; Ohkura H Gan To Kagaku Ryoho; 1988 Jul; 15(7):2107-13. PubMed ID: 2456039 [TBL] [Abstract][Full Text] [Related]
13. Elevated serum-circulating RNA in patients with conventional renal cell cancer. Feng G; Li G; Gentil-Perret A; Tostain J; Genin C Anticancer Res; 2008; 28(1A):321-6. PubMed ID: 18383864 [TBL] [Abstract][Full Text] [Related]
14. Metallopanstimulin as a novel tumor marker in sera of patients with various types of common cancers: implications for prevention and therapy. Fernandez-Pol JA Anticancer Res; 1996; 16(4B):2177-85. PubMed ID: 8694540 [TBL] [Abstract][Full Text] [Related]
15. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Müller V; Stahmann N; Riethdorf S; Rau T; Zabel T; Goetz A; Jänicke F; Pantel K Clin Cancer Res; 2005 May; 11(10):3678-85. PubMed ID: 15897564 [TBL] [Abstract][Full Text] [Related]
16. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells. Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481 [TBL] [Abstract][Full Text] [Related]
17. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis. Illert B; Fein M; Otto C; Cording F; Stehle D; Thiede A; Timmermann W Scand J Gastroenterol; 2005 Jul; 40(7):843-9. PubMed ID: 16109661 [TBL] [Abstract][Full Text] [Related]
18. Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process? Ebert W; Muley T; Drings P Anticancer Res; 1996; 16(4B):2161-8. PubMed ID: 8694537 [TBL] [Abstract][Full Text] [Related]
19. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel. Yeh CS; Wang JY; Wu CH; Chong IW; Chung FY; Wang YH; Yu YP; Lin SR Int J Oncol; 2006 Feb; 28(2):411-20. PubMed ID: 16391796 [TBL] [Abstract][Full Text] [Related]
20. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients. Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]